🇺🇸 FDA
Pipeline program

Magellan®

ART-11-004

Phase 1 other active

Quick answer

Magellan® for Acute Burns is a Phase 1 program (other) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Acute Burns
Phase
Phase 1
Modality
other
Status
active

Clinical trials